Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. (Q48269557)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 August 2017

Language	Label	Description	Also known as
English	Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.	scientific article published on 8 August 2017

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28791501

Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28791501

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Takashi Shida

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kentaro Akiyama

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Sechang Oh

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Akemi Sawai

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Tomonori Isobe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Yoshikazu Okamoto

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kazunori Ishige

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Yuji Mizokami

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kenji Yamagata

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kojiro Onizawa

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Hironori Tanaka

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Hiroko Iijima

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

8 August 2017

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28791501

Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

535-547

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28791501%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Healthy lifestyle behaviours and cardiovascular mortality among Japanese men and women: the Japan collaborative cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Six Minute Walk Test to assess functional capacity in chronic liver disease patients

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Acceleration training for managing nonalcoholic fatty liver disease: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Sarcopenia: alternative definitions and associations with lower extremity function.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Insulin resistance and muscle strength in older persons

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Sarcopenic obesity and inflammation in the InCHIANTI study

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Adipokines as regulators of muscle metabolism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

The adipocyte-myocyte axis in insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

A liver-derived secretory protein, selenoprotein P, causes insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

FGF21 reloaded: challenges of a rapidly growing field

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1377-3

21 January 2018

Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011)

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

https://pubmed.ncbi.nlm.nih.gov/28791501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48269557&oldid=1538919664"